Cells and cytokines in pulmonary cryptococcosis

Research in Immunology

Volumn 149, Issue 4-5, 1998, Pages 387-396

  Huffnagle, G B ^a   Lipscomb, M F ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTATION; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; IMMUNE SYSTEM; INFLAMMATION; LEUKOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; VIRULENCE;

EID: 0032078638     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(98)80762-1     Document Type: Article

References (79)

1. Aguirre, K., Havell, E.A., Gibson, G.W. & Johnson, L.L. (1995), Role of tumor necrosis factor alpha and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect. Immun., 63(5), 1725-1731.
2. Cauley, L.K. & Murphy, J.W. (1979), Response of congenitally athymic (nude) and phenotypically normal mice to Cryptococcus neoformans infection. Infect. Immun., 23(3), 644-651.
3. Chaturvedi, V., Wong, B. & Newman, S.L. (1996), Oxidative killing of Cryptococcus neoformans by human neutrophils. Evidence that fungal mannitol protects by scavenging reactive oxygen intermediates, J. Immunol., 156(10), 3836-3840.
4. Chen, G.H., Curtis, J.L., Mody, C.H., Christensen, P.J., Armstrong, L.R. & Toews, G.B. (1994), Effect of granulocyte-macrophage colony-stimulating factor on rat alveolar macrophage anticryptococcal activity in vitro. J. Immunol., 152(2), 724-734.
5. Collins, H.L. & Bancroft, G.J. (1991), Encapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responses. Infect. Immun., 59(11), 3883-3888.
6. Collins, H.L. & Bancroft, G.J. (1992), Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur. J. Immunol., 22(6), 1447-1454.
7. Currie, B.P. & Casadevall, A. (1994), Estimation of the prevalence of cryptococcal infection among patients infected with the human immunodeficiency virus in New York City. Clin. Infect. Dis., 19(6), 1029-1033.
8. Curtis, J.L., Huffnagle, G.B., Chen, G.H., Warnock, M.L., Gyetko, M.R., McDonald, R.A., Scott, P.J. & Toews, G.B. (1994), Experimental murine pulmonary cryptococcosis. Differences in pulmonary inflammation and lymphocyte recruitment induced by two encapsulated strains of Cryptococcus neoformans. Lab. Invest., 71(1), 113-126.
9. Diamond, R.D. (1995), Cryptococcus neoformans, in "Principles and Practice of Infectious Diseases" (G.L. Mandell, J.E. Bennett & R. Dolin) (pp. 2331-2340). Churchill Livingstone, New York.
10. Dong, Z.M. & Murphy, J.W. (1996), Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils. J. Clin. Invest., 97(3), 689-698.
11. Doyle, H.A. & Murphy, J.W. (1997), MIP-1 alpha contributes to the anticryptococcal delayed-type hypersensitivity reaction and protection against Cryptococcus neoformans. J. Leukoc. Biol., 61(2), 147-155.
12. Dykstra, M.A., Friedman, L. & Murphy, J.W. (1977), Capsule size of Cryptococcus neoformans: control and relationship to virulence. Infect. Immun., 16(1), 129-135.
13. Feldmesser, M., Casadevall, A., Kress, Y., Spira, G. & Orlofsky, A. (1997), Eosinophil-Cryptococcus neoformans interactions in vivo and in vitro. Infect. Immun., 65(5), 1899-1907.
14. Flesch, I.E., Schwamberger, G. & Kaufmann, S.H. (1989), Fungicidal activity of IFN-gamma-activated macrophages. Extracellular killing of Cryptococcus neoformans. J. Immunol., 142(9), 3219-3224.
15. Goldman, D., Cho, Y., Zhao, M., Casadevall, A. & Lee, S.C. (1996), Expression of inducible nitric oxide synthase in rat pulmonary Cryptococcus neoformans granulomas. Am. J. Pathol., 148(4), 1275-1282.
16. Goldman, D., Lee, S.C. & Casadevall, A. (1994), Pathogenesis of pulmonary Cryptococcus neoformans infection in the rat. Infect. Immun., 62(11), 4755-4761.
17. Granger, D.L., Hibbs, J.B., Jr., Perfect, J.R. & Durack, D.T. (1990), Metabolic fate of L-arginine in relation to microbiostatic capability of murine macrophages. J. Clin. Invest., 85(1), 264-273.
18. Granger, D.L., Perfect, J.R. & Durack, D.T. (1985), Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. J. Clin. Invest., 76(2), 508-516.
19. Gyetko, M.R., Chen, G.H., McDonald, R.A., Goodman, R., Huffnagle, G.B., Wilkinson, C.C., Fuller, J.A. & Toews, G.B. (1996), Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model. J. Clin. Invest., 97(8), 1818-1826.
20. Hill, J.O. (1992), CD4+ T cells cause multinucleated giant cells to form around Cryptococcus neoformans and confine the yeast within the primary site of infection in the respiratory tract. J. Exp. Med., 175(6), 1685-1695.
21. Hill, J.O. & Aguirre, K.M. (1994), CD4+ T cell-dependent acquired state of immunity that protects the brain against Cryptococcus neoformans. J. Immunol., 152(5), 2344-2350.
22. Hill, J.O. & Harmsen, A.G. (1991), Intrapulmonary growth and dissemination of an avirulent strain of Cryptococcus neoformans in mice depleted of CD4+ or CD8+ T cells. J. Exp. Med., 173(3), 755-758.
23. Hoag, K.A., Lipscomb, M.F., Izzo, A.A. & Street, N.E. (1997), IL-12 and IFN-gamma are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice. Am. J. Respir. Cell Mol. Biol., 17(6), 733-739.
24. Hoag, K.A., Street, N.B., Huffnagle, G.B. & Lipscomb, M.F. (1995), Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. Am. J. Respir. Cell Mol. Biol., 13(4), 487-495.
25. Huffnagle, G.B., Boyd, M.B., Street, N.E. & Lipscomb, M.F. (1998), IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically "susceptible" mice (C57BL/6). J. Immunol., 168 (in press).
26. Huffnagle, G.B., Chen, G.H., Curtis, J.L., McDonald, R.A., Stricter, R.M. & Toews, G.B. (1995a), Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. J. Immunol., 155(7), 3507-3516.
27. Huffnagle, G.B. & Lipscomb, M.F. (1992), Pulmonary cryptococcosis. Am. J. Pathol., 141(6), 1517-1520.
28. Huffnagle, G.B., Lipscomb, M.F., Lovchik, J.A., Hoag, K.A. & Street, N.B. (1994), The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J. Leukoc. Biol., 55(1), 35-42.
29. Huffnagle, G.B., Strieter, R.M., McNeil, L.K., McDonald, R.A., Burdick, M.D., Kunkel, S.L. & Toews, G.B. (1997), Macrophage inflammatory protein-1 alpha (MIP-1alpha) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. J. Immunol., 159(1), 318-327.
30. Huffnagle, G.B., Strieter, R.M., Standiford, T.J., McDonald, R.A., Burdick, M.D., Kunkel, S.L. & Toews, G.B. (1995b), The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection. J. Immunol., 155(10), 4790-4797.
31. Huffnagle, G.B., Toews, G.B., Burdick, M.D., Boyd, M.B., McAllister, K.S., McDonald, R.A., Kunkel, S.L. & Stricter, R.M. (1996), Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. J. Immunol., 157(10), 4529-4536.
32. Huffnagle, G.B., Yates, J.L. & Lipscomb, M.F. (1991a), Immunity to a pulmonary Cryptococcus neoformans infection requires both CD4+ and CD8+ T cells. J. Exp. Med., 173(4), 793-800.
33. Huffnagle, G.B., Yates, J.L. & Lipscomb, M.F. (1991b), T cell-mediated immunity in the lung: a Cryptococcus neoformans pulmonary infection model using SCID and athymic nude mice. Infect. Immun., 59(4), 1423-1433.
34. Jacobson, E.S. & Tinnell, S.B. (1993), Antioxidant function of fungal melanin. J. Bacteriol., 175(21), 7102-7104.
35. Kagaya, K., Yamada, T., Miyakawa, Y., Fukazawa, Y. & Saito, S. (1985), Characterization of pathogenic constituents of Cryptococcus neoformans strains. Microbiol. Immunol., 29(6), 517-532.
36. Kawakami, K., Qifeng, X., Tohyama, M., Qureshi, M.H. & Saito, A. (1996a), Contribution of tumour necrosis factor-alpha (TNF-alpha) in host defence mechanism against Cryptococcus neoformans. Clin. Exp. Immunol., 106(3), 468-474.
37. Kawakami, K., Qureshi, M.H., Zhang, T., Okamura, H., Kurimoto, M. & Saito, A. (1997a), IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-γ production. J. Immunol., 159, 5528-5534.
38. Kawakami, K., Tohyama, M., Qifeng, X. & Saito, A. (1997b), Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12. Infect. Immun., 65(4), 1307-1312.
39. Kawakami, K., Tohyama, M., Xie, Q. & Saito, A. (1996b), IL-12 protects mice against pulmonary and disseminated infection caused by Cryptococcus neoformans. Clin. Exp. Immunol., 104(2), 208-214.
40. Kawakami, K., Zhang, T., Qureshi, M.H. & Saito, A. (1997c), Cryptococcus neoformans inhibits nitric oxide production by murine peritoneal macrophages stimulated with interferon-gamma and lipopolysaccharide. Cell. Immunol., 180(1), 47-54.
41. Khakpour, F.R. & Murphy, J.W. (1987), Characterization of a third-order suppressor T cell (Ts3) induced by cryptococcal antigen(s). Infect. Immun., 55(7), 1657-1662.
42. Kozel, T.R. (1993a), Activation of the complement system by the capsule of Cryptococcus neoformans. Curr. Top. Med. Mycol., 5, 1-26.
43. Kozel, T.R. (1993b), Opsonization and phagocytosis of Cryptococcus neoformans. Arch. Med. Res., 24(3), 211-218.
44. Kozel, T.R. & Mastroianni, R.P. (1976), Inhibition of phagocytosis by cryptococcal polysaccharide: dissodation of the attachment and ingestion phases of phagocytosis. Infect. Immun., 14(1), 62-67.
45. Kwon-Chung, K.J. & Rhodes, J.C. (1986), Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect. Immun., 51(1), 218-223.
46. Levitz, S.M. (1991), Activation of human peripheral blood mononuclear cells by interleukin-2 and granulocyte-macrophage colony-stimulating factor to inhibit Cryptococcus neoformans. Infect. Immun., 59(10), 3393-3397.
47. Levitz, S.M. & DiBenedetto, D.J. (1988), Differential stimulation of murine resident peritoneal cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans. Infect. Immun., 56(10), 2544-2551.
48. Levitz, S.M., Mathews, H.L. & Murphy, J.W. (1995), Direct antimicrobial activity of T cells. Immunol. Today, 16(8), 387-391.
49. Levitz, S.M., North, E.A., Jiang, Y., Nong, S.H., Kornfeld, H. & Harrison, T.S. (1997), Variables affecting production of monocyte chemotactic factor 1 from human leukocytes stimulated with Cryptococcus neoformans. Infect. Immun., 65(3), 903-908.
50. Levitz, S.M., Tabuni, A., Kornfeld, H., Reardon, C.C. & Golenbock, D.T. (1994), Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect. Immun., 62(5), 1975-1981.
51. Levitz, S.M., Tabuni, A., Nong, S.H. & Golenbock, D.T. (1996), Effects of interleukin-10 on human peripheral blood mononuclear cell responses to Cryptococcus neoformans, Candida albicans, and lipopolysaccharide. Infect. Immun., 64(3), 945-951.
52. Levitz, S.M., Tabuni, A., Wagner, R., Kornfeld, H. & Smail, E.H. (1992), Binding of unopsonized Cryptococcus neoformans by human bronchoalveolar macrophages: inhibition by a large-molecular-size serum component. J. Infect. Dis., 166(4), 866-873.
53. Lim, T.S., Murphy, J.W. & Cauley, L.K. (1980), Hostetiological agent interactions in intranasally and intraperitoneally induced cryptococcosis in mice. Infect. Immun., 29(2), 633-641.
54. Lipscomb, M.F., Bice, D.E., Lyons, C.R., Schuyler, M.R. & Wilkes, D. (1995), The regulation of pulmonary immunity. Adv. Immunol., 59, 369-455.
55. Lovchik, J., Lipscomb, M. & Lyons, C.R. (1997), Expression of lung inducible nitric oxide synthase protein does not correlate with nitric oxide production in vivo in a pulmonary immune response against Cryptococcus neoformans. J. Immunol., 158(4), 1772-1778.
56. Lovchik, J.A. & Lipscomb, M.F. (1993), Role for C5 and neutrophils in the pulmonary intravascular clearance of circulating Cryptococcus neoformans. Am. J. Respir. Cell Mol. Biol., 9(6), 617-627.
57. Lovchik, J.A., Lyons, C.R. & Lipscomb, M.F. (1995), A role for gamma interferon-induced nitric oxide in pulmonary clearance of Cryptococcus neoformans. Am. J. Respir. Cell Mol. Biol., 13(1), 116-124.
58. Lyons, C.R. & Lipscomb, M.F. (1983), Alveolar macrophages in pulmonary immune responses. I. Role in the initiation of primary immune responses and in the selective recruitment of T lymphocytes to the lung. J. Immunol., 130(3), 1113-1119.
59. Mody, C.H., Chen, G.H., Jackson, C., Curtis, J.L. & Toews, G.B. (1993a), Depletion of murine CD8+ T cells in vivo decreases pulmonary clearance of a moderately virulent strain of Cryptococcus neoformans. J. Lab. Clin. Med., 121(6), 765-773.
60. Mody, C.H., Chen, G.H., Jackson, C., Curtis, J.L. & Toews, G.B. (1994a), In vivo depletion of murine CD8 positive T cells impairs survival during infection with a highly virulent strain of Cryptococcus neoformans. Mycopathologia, 125(1), 7-17.
61. Mody, C.H., Paine, R., 3rd, Jackson, C., Chen, G.H. & Toews, G.B. (1994b), CD8 cells play a critical role in delayed type hypersensitivity to intact Cryptococcus neoformans. J. Immunol., 152(8), 3970-3979.
62. Mody, C.H., Paine, R. d., Jackson, C.J. & Toews, G.B. (1993b), CD8 cells mediate delayed hypersensitivity following intrapulmonary infection with Cryptococcus neoformans. Chest, 103(2 Suppl), 118S.
63. Mody, C.H., Tyler, C.L., Sitrin, R.G., Jackson, C. & Toews, G.B. (1991), Interferon-gamma activates rat alveolar macrophages for anticryptococcal activity. Am. J. Respir. Cell Mol. Biol., 5(1), 19-26.
64. Monari, C., Retini, C., Palazzetti, B., Bistoni, F. & Vecchiarelli, A. (1997), Regulatory role of exogenous IL-10 in the development of immune response versus Cryptococcus neoformans. Clin. Exp. Immunol., 109(2), 242-247.
65. Murphy, J.W. (1985), Effects of first-order Cryptococcus-specific T-suppressor cells on induction of cells responsible for delayed-type hypersensitivity. Infect. Immun., 48(2), 439-445.
66. Murphy, J.W. (1989), Clearance of Cryptococcus neoformans from immunologically suppressed mice. Infect. Immun., 57(7), 1946-1952.
67. Murphy, J.W. & Moorhead, J.W. (1982), Regulation of cell-mediated immunity in cryptococcosis. I. Induction of specific afferent T suppressor cells by cryptococcal antigen. J. Immunol., 128(1), 276-283.
68. Murphy, J.W. & Mosley, R.L. (1985), Regulation of cell-mediated immunity in cryptococcosis. III. Characterization of second-order T suppressor cells (Ts2). J. Immunol., 134(1), 577-584.
69. Murphy, J.W., Mosley, R.L. & Moorhead, J.W. (1983), Regulation of cell-mediated immunity in cryptococcosis. II. Characterization of first-order T suppressor cells (Ts1) and induction of second-order suppressor cells. J. Immunol., 130(6), 2876-2881.
70. Murphy, J.W., Zhou, A. & Wong, S.C. (1997), Direct interactions of human natural killer cells with Cryptococcus neoformans inhibit granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha production. Infect. Immun., 65(11), 4564-4571.
71. Nosanchuk, J.D. & Casadevall, A. (1997), Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding. Infect. Immun., 65(5), 1836-1841.
72. Schelenz, S., Malhotra, R., Sim, R.B., Holmskov, U. & Bancroft, G.J. (1995), Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells. Infect. Immun., 63(9), 3360-3366.
73. Vecchiarelli, A., Dottorini, M., Pietrella, D., Monari, C., Retini, C., Todisco, T. & Bistoni, F. (1994a), Role of human alveolar macrophages as antigen-presenting cells in Cryptococcus neoformans infection. Am. J. Respir. Cell Mol. Biol., 11(2), 130-137.
74. Vecchiarelli, A., Pietrella, D., Dottorini, M., Monari, C., Retini, C., Todisco, T. & Bistoni, F. (1994b), Encapsulation of Cryptococcus neoformans regulates fungicidal activity and the antigen presentation process in human alveolar macrophages. Clin. Exp. Immunol., 98(2), 217-223.
75. Vecchiarelli, A., Retini, C., Monari, C., Tascini, C., Bistoni, F. & Kozel, T.R. (1996), Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes. Infect. Immun., 64(7), 2846-2849.
76. Vecchiarelli, A., Retini, C., Pietrella, D., Monari, C., Tascini, C., Beccari, T. & Kozel, T.R. (1995), Downregulation by cryptococcal polysaccharide of tumor necrosis factor alpha and interleukin-1 beta secretion from human monocytes. Infect. Immun., 63(8), 2919-2923.
77. Wang, Y. & Casadevall, A. (1994a), Growth of Cryptococcus neoformans in presence of L-dopa decreases its susceptibility to amphotericin B. Antimicrob. Agents Chemother., 38(11), 2648-2650.
78. Wang, Y. & Casadevall, A. (1994b), Susceptibility of melanized and nonmelanized Cryptococcus neoformans to nitrogen-and oxygen-derived oxidants. Infect. Immun., 62(7), 3004-3007.
79. Zhang, T., Kawakami, K., Qureshi, M.H., Okamura, H., Kurimoto, M. & Saito, A. (1997), Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Infect. Immun., 65(9), 3594-3599.